EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

The Impact of Metachronous Colorectal Neoplasia Requiring Surgery After Cessation of Colonoscopic Surveillance at Age 75

Ammar Manasawala, John Woodfield, Kari Clifford iD, Mark Thompson Fawcett

ANZ Journal of Surgery · 2025

DOI: 10.1111/ans.70199 ↗

At a glance

Journal article in ANZ Journal of Surgery, 2025. Written by Ammar Manasawala and 3 co-authors. Institution: Department of Surgical Sciences, Otago Medical School, University of Otago, Dunedin, New Zealand. Major MEDLINE topics: Colorectal Neoplasms, Colonoscopy, Neoplasms, Second Primary. 22 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

To assess the clinical and financial impact of metachronous colorectal neoplasia (MCRN) requiring surgery after cessation of colonoscopic surveillance at age 75.

Methods

The Otago Clinical Audit database was interrogated to identify all colorectal neoplasia (CRN) resections between January 2020 and November 2022 and additional patients undergoing surgery for MCRN aged ≥ 75 (MCRN ≥ 75) between 2010 and 2020. The morbidity, hospital stay, and costs of surgery for MCRN ≥ 75 cases were compared to first colorectal neoplasia (FCRN) cases ≥ 75 and to all other colorectal resections, with and without propensity matching.

Results

MCRN was identified in 3.1% of patients < 75 and 13.1% of patients ≥ 75. Identifying a further 41 patients with surgery for MCRN ≥ 75 after 2010 resulted in 55 patients with MCRN aged ≥ 75, 93 with FCRN aged ≥ 75, and 130 with CRN aged < 75. The median(IQR) age for MCRN ≥ 75 was 81 (78–86). Surgery for MCRN ≥ 75 compared to FCRN ≥ 75 resulted in complication rates of 70.9% and 50.5% ( p = 0.024), hospital stay nine versus seven days ( p = 0.012), readmissions 20% versus 6.5% ( p = 0.026) and cost of NZD 31 021 versus 24 157 ( p = 0.028). When compared to all other resections, and adjusting for different approaches to rectal cancer in elderly patients, these differences all increased. The estimated annual hospital cost for MCRN ≥ 75 surgery was NZD 317 777.

Conclusion

MCRN accounted for 13.1% of operations in patients aged ≥ 75. This resulted in more morbidity and cost than surgery for FCRN ≥ 75. Stopping surveillance of those with previous surgery for CRN at 75 years of age results in significant institutional cost and patient morbidity.

Subjects

MeSH terms (MEDLINE)

Colorectal NeoplasmsColonoscopyNeoplasms, Second PrimaryHumansAgedMaleFemaleAged, 80 and overLength of StayNew ZealandRetrospective StudiesAge FactorsColectomy

Author keywords

colorectal surgerycolorectal surveillancemetachronous colorectal neoplasia

Authors and institutions

  • Department of Surgical Sciences, Otago Medical School, University of Otago, Dunedin, New Zealand.

ORCID profiles: Kari Clifford

Cite

APA

Manasawala, A., Woodfield, J., Clifford, K., & Thompson Fawcett, M. (2025). The Impact of Metachronous Colorectal Neoplasia Requiring Surgery After Cessation of Colonoscopic Surveillance at Age 75. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70199

Vancouver

Manasawala A, Woodfield J, Clifford K, Thompson Fawcett M. The Impact of Metachronous Colorectal Neoplasia Requiring Surgery After Cessation of Colonoscopic Surveillance at Age 75. ANZ Journal of Surgery. 2025. doi:10.1111/ans.70199

BibTeX
@article{Manasawala2025,
  author = {Manasawala, Ammar and Woodfield, John and Clifford, Kari and Thompson Fawcett, Mark},
  title = {The Impact of Metachronous Colorectal Neoplasia Requiring Surgery After Cessation of Colonoscopic Surveillance at Age 75},
  journal = {ANZ Journal of Surgery},
  year = {2025},
  doi = {10.1111/ans.70199}
}
Start for free →